A trial of fecal microbiota transplantation and / or antibiotics therapy for ulcerative colitis

A trial of fecal microbiota transplantation and / or antibiotics therapy for ulcerative colitis - A trial of fecal microbiota transplantation and / or antibiotics therapy for ulcerative colitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018642

Enrollment

Registered

2015-08-11

Start date

2015-08-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

Antibiotics therapy:Taking three kinds of antibiotics (Amoxicillin, fosmycin, metronidazole) for two weeks. FMT:Administration of the fecal material from healthy donors to patients.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Ulcerative colitis patients 2. Donors should be more than 20 years old.

Exclusion criteria

Exclusion criteria: 1. Patients who have severe drug allergy are excluded. 2. Donors who show abnormal findings to the screening tests including blood and feces.

Design outcomes

Primary

Measure	Time frame
Efficacy of this treatment is evaluted by microbiota analysis, endoscopic score and bllod test.	—

Countries

Japan

Contacts

Public ContactDai Ishikawa

Juntendo university school of medicine Department of gastroenterology

dai@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026